I found the arguments lacking. I don't think there was any plan on preventing infection on the first batch of vaccines, and even the FDA does recommend a minimum of 50% efficacy.

Infection prevention or preventing severe symptoms, are however part of the secondary endpoints of the trials, something that it is not mentioned in the article.

For a counter argument, see https://mobile.twitter.com/nataliexdean/status/1308474303810...